UNSPSC 51184010: Gliquidone

This classification denotes an anti-diabetic agent with the molecular formula C27H33N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) C7C2QDD75P, chemically known as 1-cyclohexyl-3-(p-beta-(4,4-dimethyl-2-methoxy-1,3-(2h,4h)-isoquinolinedione-2-yl)phenethyl)sulfonylurea but more generally known as gliquidone, which bears US NIH Compound Identifier 91610. European Medicines Agency schedules Gliquidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07928MIG.

UNSPSC 51184010 Gliquidone is a Commodity code covering a specific oral antidiabetic drug used in diabetes management. The source provides no recent state and local contract opportunities soliciting this pharmaceutical product. Without posted solicitations or requisitions, the code shows no current procurement activity to evaluate for business development purposes.

State and local health systems, correctional facilities, and public health agencies theoretically purchase pharmaceuticals under related family codes, but this specific commodity code has not generated identifiable recent RFP, RFQ, IFB, or ITT activity in the available opportunity records. Absence of activity does not indicate zero procurement — many state and local pharmaceutical acquisitions flow through group purchasing organizations, state healthcare cooperative agreements, or standing contracts negotiated at higher aggregation tiers — but no ground-level solicitation evidence supports pursuit under this code at this time.